Nachrichten zur CRISPR Therapeutics AG Aktie

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $54.74, indicating a -2.2% shift from the previous…

CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.…

CRISPR Therapeutics AG (CRSP) Stock Moves -2.51%: What You Should Know

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.…

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Heres Why

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $67.21, denoting a +1.04% move from…

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $68.29, indicating a -6.54% shift from the previous…

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $74.89, moving 2.46% from the previous trading session.…

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

CRISPR Therapeutics AG (CRSP) reached $67.74 at the closing of the latest trading day, reflecting a -6.98% change compared to…

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Heres Why

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day.…

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $60.62, marking a -2.38% move from the previous day.…

CRISPR Therapeutics Aktie: Starke Bewertung durch Casgevy und 2 Mrd. USD Cash - Coverageaufnahme!

New York (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von J.P. Morgan Securities:Der Analyst Brian Cheng von JPMorgan hat die Coverage der Aktie…

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +12.24% and -86.45%, respectively, for the quarter ended June 2025. Do…

Crispr Therapeutics shares tumble after significant earnings miss By Investing.com

Crispr Therapeutics shares tumble after significant earnings miss…

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $56.26, indicating a -2.46% shift from the previous…

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $64.76, signifying a -1.97% move from its prior days close.…

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $66.06, moving 3.05% from the previous trading session.…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $52.73, denoting a -6.54% move from…

Heres Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $51.19, representing a -1.88% change from its previous close.…

2 Beaten-Down Stocks With Massive Upside Potential

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues…

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be…

CRISPR Therapeutics AG (CRSP) Stock Moves 1.88%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.66, moving +1.88% from the previous trading session.…

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.…

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $46.78, marking a +2.7% move from the previous day.…

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

If youre looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening…

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Heres What You Need to Know

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $44.43, representing a +2.87% change from its previous close.…

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $42.94, representing a +2.02% change from its previous close.…

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

…

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

Even though broader equities have been highly volatile this year, its still a good idea to invest in stocks for…

CRISPR Therapeutics: Neue Kooperation – das steckt dahinter

Der weltweit führende CRISPR-Spezialist hat am Montag eine hochinteressante Zusammenarbeit bekanntgegeben. Gemeinsam mit Sirius Therapeutics sollen neuartige siRNA-Therapien zur Marktreife…

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The companys…

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

One of the biggest opportunities in healthcare today centers around genome editing. According to analysts at Grand View Research, the…

2 Biotech Stocks That Are Screaming Buys in May

Its very tempting to pile into the stocks with the strongest positive momentum of the moment -- theyve proven themselves…

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -24.41% and 83.48%, respectively, for the quarter ended March 2025. Do…

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.25, moving +1.38% from the previous trading session.…

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the…

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $39.11, marking a +1.48% move from the previous day.…

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $38.54, denoting a -1.76% change from…

5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years

A "monster stock" might be one that frightens you by free-falling. Or it might alarm you with characteristics such as…

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $37.77, representing a -0.03% change from its previous close.…

3 Magnificent Stocks That Could Double or More by 2030

When the stock market is as turbulent as it is these days, its easy to forget the times when things…

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire,…

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $34.26, moving -1.81% from the previous trading session.…

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

…

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year,…

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $32.65 in the latest trading session, marking a -0.03% move from the prior day.…

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP)…

Crispr Therapeutics Aktie: Verliert ihren Kurs?

Der Austritt des operativen Geschäftsführers beim Gentherapie-Unternehmen beunruhigt Investoren und wirft Fragen zur Projektkontinuität im wettbewerbsintensiven Biotech-Sektor auf. Die Finanzmärkte...…

2 Beaten-Down Stocks to Buy on the Dip

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to…

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $41.22, indicating a +0.12% shift from the previous…

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day.…